Urologic cancers are some of the most common types of cancers today. In fact, the American Cancer Society® states that:
- About 1 in 8 men will be diagnosed with prostate cancer during his lifetime.
- Bladder cancer accounts for about 7% of all new cancers in the U.S.
- Kidney cancer is among the 10 most common cancers in both men and women. Overall, the lifetime risk for developing kidney cancer is about 1 in 63.
- About 1 in every 263 males will develop testicular cancer at some point during his life.
There are several types of cancer that fall under the umbrella of urologic cancer:
The highly trained urologists at New Jersey Urology (NJU) offer cutting-edge diagnostics and treatment for urologic cancers, including robotic urologic surgery, chemotherapy and radiation therapy. Our physicians are at the forefront in the best of non-invasive and minimally invasive treatment and care for these types of cancers and other urologic conditions.
PATIENT SUCCESS STORIES
Meet Michael Secli, a prostate cancer survivor, describes his journey through radiation treatment along with participating in an immunotherapy clinical trial – all provided through New Jersey Urology’s state-of-the-art advanced Cancer Treatment Center. Hear from his urologic oncologist, Dr. Glen Gejerman, as he explains the treatment options and the science behind immunotherapy treatment.